Research suggests that prior authorization has negative effects on patients with cancer and oncology providers.

The FDA has approved Imuldosa, a biosimilar to Stelara (ustekinumab), for the treatment of various chronic inflammatory diseases.

The per member per month (PMPM) health care costs for members with insomnia were 4 to 6 times higher than those without insomnia.

Native Hawaiian and Pacific Islander adults have a high rate of cardiovascular disease mortality, according to study findings.

Unemployment, neurological deficit, and some treatments increase the likelihood adult survivors of childhood cancer retain a fear of recurrence or SMN.

Psilocybin-assisted psychotherapy can help patients with cancer with a range of psychiatric symptoms, according to a recent study.

For disease-specific survival in malignant adnexal tumors of the skin, Mohs micrographic surgery is superior to wide local excision and no treatment.

The MVA-BN vaccine, licensed in the United States to prevent smallpox and mpox, is well tolerated and seems effective in adolescents.

Precocious puberty is associated with approximately 2-fold greater odds of hidradenitis suppurativa, regardless of patient-specific characteristics.

Studies have shown that prior authorization can create administrative burdens for providers and patients, delay care, force patients to receive suboptimal treatment, and cause adverse events, ...

ON101 is more effective than absorbent dressings for the treatment of diabetic foot ulcers among patients with risk factors that delay wound healing.

Despite having a worse clinicopathogic profile, patients with CHNM had a better response to ICI therapy when compared with patients with CMOS.